The mechanism of antimalarial action of ellagic acid on haemoglobin metabolism in plasmodium falciparum

Malaria caused by Plasmodium parasites has afflicted humans since ancient times. Due to the prevalence of drug-resistant P. falciparum, the effectiveness of the standard antimalarial drugs has decreased, requiring research into the development of new antimalarial drugs with novel targets. Ellagic ac...

Full description

Saved in:
Bibliographic Details
Main Author: Thuduhena, Thuduhenage Dona Anjana Chamilka
Format: Thesis
Language:English
Published: 2024
Subjects:
Online Access:http://eprints.usm.my/61034/1/THUDUHENAGE%20DONA%20ANJANA%20CHAMILKA%20THUDUHENA-FT%20P-SKM000121%28R%29-E.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
id my-usm-ep.61034
record_format uketd_dc
spelling my-usm-ep.610342024-10-13T02:51:53Z The mechanism of antimalarial action of ellagic acid on haemoglobin metabolism in plasmodium falciparum 2024-04 Thuduhena, Thuduhenage Dona Anjana Chamilka G Geography. Anthropology. Recreation R Medicine RC109-216 Infectious and parasitic diseases Malaria caused by Plasmodium parasites has afflicted humans since ancient times. Due to the prevalence of drug-resistant P. falciparum, the effectiveness of the standard antimalarial drugs has decreased, requiring research into the development of new antimalarial drugs with novel targets. Ellagic acid has been shown to have antimalarial activity against P. falciparum in vitro by inhibiting the formation of beta-haematin (haemozoin) in the mature stage parasite. The present study aimed to elucidate the mechanism of antimalarial action of ellagic acid on haemoglobin ingestion, transport and digestion in chloroquine-sensitive (3D7) and chloroquine-resistant (W2) strains of P. falciparum in vitro. The antimalarial activity of ellagic acid that inhibits 50% of the parasite population (IC50) was determined using a malarial SYBR Green I fluorescence-based (MSF) assay with artemisinin was used as a standard drug. Based on the IC50 value of ellagic acid, early trophozoite stage parasites were incubated with the compound at different concentrations for 8 hours before Giemsa-stained thin blood smears were prepared and viewed by light microscopy. The concentrations of 3.0 and 3.9 nM were selected to observe the maximum effect of ellagic acid on early trophozoite stage of 3D7 and W2 parasites, respectively by transmission electron microscopy. Jasplakinolide (7 μM) and E-64 (10μM) were used as control drugs. The results show that ellagic acid significantly inhibited (p < 0.001) 3D7 and W2 parasites with IC50 values of 1.0 ± 0.7 and 1.3 ± 0.1 nM, respectively as compared with artemisinin (IC50-3D7 parasite = 2.2 ± 0.2 nM; IC50-W2 parasite = 4.3 ± 0.3 nM). The results show that shrunken parasites were observed in all ellagic acid-treated groups of 3D7 and W2 parasites. The results show the formation of 3D7: 3 ± 2 and W2: 4 ± 2 haemoglobin-containing cytostomal sections, indicating the inhibition of haemoglobin uptake in the ellagic acid-treated 3D7 and W2 parasites. Only 3 ± 1 cytostomal sections were observed in the jasplakinolide-treated 3D7 parasite, 2 ± 1 cytostomal section was observed in the jasplakinolide-treated W2 parasite. The haemoglobin-containing transport vesicle was not observed in the ellagic acid and jasplakinolide-treated 3D7 and W2 parasites. As compared with the control of non-treated parasites, the high contrast and enlarged digestive vacuole was observed in the ellagic acid and E-64-treated 3D7 and W2 parasites. In conclusion, ellagic acid has the potential to be a new antimalarial drug targeting haemoglobin ingestion, transport and digestion of chloroquine-sensitive and chloroquine-resistant strains of P. falciparum. 2024-04 Thesis http://eprints.usm.my/61034/ http://eprints.usm.my/61034/1/THUDUHENAGE%20DONA%20ANJANA%20CHAMILKA%20THUDUHENA-FT%20P-SKM000121%28R%29-E.pdf application/pdf en public masters Universiti Sains Malaysia Pusat Pengajian Sains Perubatan
institution Universiti Sains Malaysia
collection USM Institutional Repository
language English
topic G Geography
Anthropology
Recreation
R Medicine
RC109-216 Infectious and parasitic diseases
spellingShingle G Geography
Anthropology
Recreation
R Medicine
RC109-216 Infectious and parasitic diseases
Thuduhena, Thuduhenage Dona Anjana Chamilka
The mechanism of antimalarial action of ellagic acid on haemoglobin metabolism in plasmodium falciparum
description Malaria caused by Plasmodium parasites has afflicted humans since ancient times. Due to the prevalence of drug-resistant P. falciparum, the effectiveness of the standard antimalarial drugs has decreased, requiring research into the development of new antimalarial drugs with novel targets. Ellagic acid has been shown to have antimalarial activity against P. falciparum in vitro by inhibiting the formation of beta-haematin (haemozoin) in the mature stage parasite. The present study aimed to elucidate the mechanism of antimalarial action of ellagic acid on haemoglobin ingestion, transport and digestion in chloroquine-sensitive (3D7) and chloroquine-resistant (W2) strains of P. falciparum in vitro. The antimalarial activity of ellagic acid that inhibits 50% of the parasite population (IC50) was determined using a malarial SYBR Green I fluorescence-based (MSF) assay with artemisinin was used as a standard drug. Based on the IC50 value of ellagic acid, early trophozoite stage parasites were incubated with the compound at different concentrations for 8 hours before Giemsa-stained thin blood smears were prepared and viewed by light microscopy. The concentrations of 3.0 and 3.9 nM were selected to observe the maximum effect of ellagic acid on early trophozoite stage of 3D7 and W2 parasites, respectively by transmission electron microscopy. Jasplakinolide (7 μM) and E-64 (10μM) were used as control drugs. The results show that ellagic acid significantly inhibited (p < 0.001) 3D7 and W2 parasites with IC50 values of 1.0 ± 0.7 and 1.3 ± 0.1 nM, respectively as compared with artemisinin (IC50-3D7 parasite = 2.2 ± 0.2 nM; IC50-W2 parasite = 4.3 ± 0.3 nM). The results show that shrunken parasites were observed in all ellagic acid-treated groups of 3D7 and W2 parasites. The results show the formation of 3D7: 3 ± 2 and W2: 4 ± 2 haemoglobin-containing cytostomal sections, indicating the inhibition of haemoglobin uptake in the ellagic acid-treated 3D7 and W2 parasites. Only 3 ± 1 cytostomal sections were observed in the jasplakinolide-treated 3D7 parasite, 2 ± 1 cytostomal section was observed in the jasplakinolide-treated W2 parasite. The haemoglobin-containing transport vesicle was not observed in the ellagic acid and jasplakinolide-treated 3D7 and W2 parasites. As compared with the control of non-treated parasites, the high contrast and enlarged digestive vacuole was observed in the ellagic acid and E-64-treated 3D7 and W2 parasites. In conclusion, ellagic acid has the potential to be a new antimalarial drug targeting haemoglobin ingestion, transport and digestion of chloroquine-sensitive and chloroquine-resistant strains of P. falciparum.
format Thesis
qualification_level Master's degree
author Thuduhena, Thuduhenage Dona Anjana Chamilka
author_facet Thuduhena, Thuduhenage Dona Anjana Chamilka
author_sort Thuduhena, Thuduhenage Dona Anjana Chamilka
title The mechanism of antimalarial action of ellagic acid on haemoglobin metabolism in plasmodium falciparum
title_short The mechanism of antimalarial action of ellagic acid on haemoglobin metabolism in plasmodium falciparum
title_full The mechanism of antimalarial action of ellagic acid on haemoglobin metabolism in plasmodium falciparum
title_fullStr The mechanism of antimalarial action of ellagic acid on haemoglobin metabolism in plasmodium falciparum
title_full_unstemmed The mechanism of antimalarial action of ellagic acid on haemoglobin metabolism in plasmodium falciparum
title_sort mechanism of antimalarial action of ellagic acid on haemoglobin metabolism in plasmodium falciparum
granting_institution Universiti Sains Malaysia
granting_department Pusat Pengajian Sains Perubatan
publishDate 2024
url http://eprints.usm.my/61034/1/THUDUHENAGE%20DONA%20ANJANA%20CHAMILKA%20THUDUHENA-FT%20P-SKM000121%28R%29-E.pdf
_version_ 1818647369115238400